InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Leamon Christopher P. Director active across 2 companies, notably ENDOCYTE INC. In total, 5 disclosures have been published. Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Leamon Christopher P is a declarant linked to ENDOCYTE INC, where he was Vice President of Research, and to Fusion Pharmaceuticals Inc., where he was Chief Scientific Officer. He has 5 filings in total, and across the 5 sampled filings from 2016-02-08 to 2024-06-04, the most common transaction nature is Attribution, with 0 EUR of buys and 0 EUR of sells.